MLXIPL
Basic information
Region (hg38): 7:73593194-73624543
Previous symbols: [ "WBSCR14" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (113 variants)
- not_provided (52 variants)
- Williams_syndrome (2 variants)
- MLXIPL-related_disorder (1 variants)
- Myoepithelial_tumor (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MLXIPL gene is commonly pathogenic or not. These statistics are base on transcript: NM_000032951.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 23 | 29 | ||||
missense | 103 | 18 | 128 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 104 | 41 | 13 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MLXIPL | protein_coding | protein_coding | ENST00000313375 | 17 | 31350 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0478 | 0.952 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.23 | 391 | 466 | 0.839 | 0.0000298 | 5359 |
Missense in Polyphen | 162 | 190.92 | 0.84853 | 2234 | ||
Synonymous | 0.891 | 179 | 195 | 0.919 | 0.0000121 | 1804 |
Loss of Function | 3.90 | 9 | 33.2 | 0.271 | 0.00000161 | 381 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000139 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000102 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000661 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor. Binds to the canonical and non-canonical E box sequences 5'-CACGTG-3' (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Note=WBSCR14 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of WBSCR14 may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. {ECO:0000269|PubMed:10780788}.;
- Pathway
- Insulin resistance - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Metformin Pathway, Pharmacodynamic;Angiopoietin Like Protein 8 Regulatory Pathway;Liver steatosis AOP;chrebp regulation by carbohydrates and camp;PKA-mediated phosphorylation of key metabolic factors;AMPK inhibits chREBP transcriptional activation activity;PP2A-mediated dephosphorylation of key metabolic factors;Metabolism;ChREBP activates metabolic gene expression;Integration of energy metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.427
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.87
Haploinsufficiency Scores
- pHI
- 0.737
- hipred
- Y
- hipred_score
- 0.703
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mlxipl
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;positive regulation of cell population proliferation;anatomical structure morphogenesis;glucose mediated signaling pathway;negative regulation of peptidyl-serine phosphorylation;intracellular signal transduction;glucose homeostasis;positive regulation of fatty acid biosynthetic process;positive regulation of glycolytic process;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of lipid biosynthetic process;fatty acid homeostasis;triglyceride homeostasis;negative regulation of cell cycle arrest;negative regulation of oxidative phosphorylation;energy homeostasis
- Cellular component
- nucleus;nucleoplasm;transcription factor complex;cytoplasm;cytosol
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription factor binding;carbohydrate response element binding;protein homodimerization activity;protein heterodimerization activity